Traumatic Brain Injury News and Research

RSS
Traumatic brain injury (TBI), a form of acquired brain injury, occurs when a sudden trauma causes damage to the brain. TBI can result when the head suddenly and violently hits an object, or when an object pierces the skull and enters brain tissue. Symptoms of a TBI can be mild, moderate, or severe, depending on the extent of the damage to the brain. A person with a mild TBI may remain conscious or may experience a loss of consciousness for a few seconds or minutes. Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. A person with a moderate or severe TBI may show these same symptoms, but may also have a headache that gets worse or does not go away, repeated vomiting or nausea, convulsions or seizures, an inability to awaken from sleep, dilation of one or both pupils of the eyes, slurred speech, weakness or numbness in the extremities, loss of coordination, and increased confusion, restlessness, or agitation.
New center opens for vets with traumatic brain injuries and psychological issues

New center opens for vets with traumatic brain injuries and psychological issues

National Intrepid Center of Excellence to treat veterans with traumatic brain injury

National Intrepid Center of Excellence to treat veterans with traumatic brain injury

Athersys, CSCRM and CWRU receive $1M to advance MultiStem therapy for SCI

Athersys, CSCRM and CWRU receive $1M to advance MultiStem therapy for SCI

Healthcare technology innovation projects to receive $3M in CIMIT medical research grants

Healthcare technology innovation projects to receive $3M in CIMIT medical research grants

Antibody treatment could significantly improve lives following spinal cord injury: Researchers

Antibody treatment could significantly improve lives following spinal cord injury: Researchers

Sinapis initiates dosing in Phase I trial of intravenous infusion of methamphetamine

Sinapis initiates dosing in Phase I trial of intravenous infusion of methamphetamine

Oxygen Biotherapeutics' common stock approved for secondary listing on SIX Swiss Exchange

Oxygen Biotherapeutics' common stock approved for secondary listing on SIX Swiss Exchange

Biomechanical implications of low-height falls in toddlers

Biomechanical implications of low-height falls in toddlers

Certain PTSD symptoms may be key to treating anger among Iraq/Afghanistan Veterans: Study

Certain PTSD symptoms may be key to treating anger among Iraq/Afghanistan Veterans: Study

Evidence-based review of TBI in sport

Evidence-based review of TBI in sport

New AAN guideline provides step-by-step process for determining brain death in adults

New AAN guideline provides step-by-step process for determining brain death in adults

In the news: Senate and jobs bill; Obama appeals to seniors; States' Medicaid squeeze; Beyond COBRA

In the news: Senate and jobs bill; Obama appeals to seniors; States' Medicaid squeeze; Beyond COBRA

KMI receives $2.8M grant to support delivery of teletherapy service to stroke survivors in rural areas

KMI receives $2.8M grant to support delivery of teletherapy service to stroke survivors in rural areas

Prismatic eyeglass lenses reduce symptoms associated with TBI, vertical heterophoria: Study

Prismatic eyeglass lenses reduce symptoms associated with TBI, vertical heterophoria: Study

Oxycyte perfluorocarbon emulsion demonstrates marked neuroprotective effect in rat model of spinal cord injury

Oxycyte perfluorocarbon emulsion demonstrates marked neuroprotective effect in rat model of spinal cord injury

State roundup: Health law could be critical for Miss.'s poor; Colorado passes end-of-life care laws, Penn. details plan for high risk pool

State roundup: Health law could be critical for Miss.'s poor; Colorado passes end-of-life care laws, Penn. details plan for high risk pool

Phase II trial of NUVIGIL Tablets for treatment of schizophrenia fails to meet primary endpoint: Cephalon

Phase II trial of NUVIGIL Tablets for treatment of schizophrenia fails to meet primary endpoint: Cephalon

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

CDP-choline may block skull and brain damage that result from alcohol consumption early in pregnancy

CDP-choline may block skull and brain damage that result from alcohol consumption early in pregnancy

Anaheim Regional Medical Center uses Arctic Sun cooling device to protect a patient from brain damage

Anaheim Regional Medical Center uses Arctic Sun cooling device to protect a patient from brain damage

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.